Evidence map›Paper›PMID 34639486›Full record

ArticleInternational journal of environmental research and public health2021

Simple Disposable Odor Identification Tests for Predicting SARS-CoV-2 Positivity.

Laura Ziuzia-Januszewska, Paweł Dobrzyński, Krzysztof Ślączka, Jaromir Ciszek, Łukasz Krawiec, Waldemar Wierzba, Artur Zaczyński

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura Ziuzia-JanuszewskaDepartment of Otolaryngology, Central Clinical Hospital of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Paweł DobrzyńskiDepartment of Otolaryngology, Central Clinical Hospital of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Krzysztof ŚlączkaDepartment of Otolaryngology, Central Clinical Hospital of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Jaromir CiszekDepartment of Otolaryngology, Central Clinical Hospital of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Łukasz KrawiecDepartment of Otolaryngology, Central Clinical Hospital of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.
Waldemar WierzbaUHE Satellite Campus, University of Humanities and Economics, 01-513 Warsaw, Poland.
Artur ZaczyńskiCentral Clinical Hospital of the Ministry of the Interior and Administration, 02-507 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olfactory dysfunction (OD) is a common manifestation of COVID-19 and may be useful for screening. Survey-based olfactory evaluation tends to underestimate the prevalence of OD, while psychophysical olfactory testing during a pandemic has the disadvantage of being time consuming, expensive, and requiring standardized laboratory settings. We aimed to develop a quick, simple, affordable, and reliable test to objectively assess the prevalence and diagnostic accuracy of OD in COVID-19. The olfactory function of 64 COVID-19 inpatients and 34 controls was evaluated using a questionnaire and a simple disposable odor identification test (SDOIT) developed for this study. Four SDOIT models were assessed: 10-SDOIT, 9-SDOIT, 8-SDOIT, and 4-SDOIT, with 10, 9, 8 and 4 samples, respectively. We found a high frequency of self-reported OD in COVID-19 patients, with 32.8% and 42.2% reporting current and recent OD, respectively. Different SDOIT models revealed smell impairment in 54.7-64.1% of COVID-19 patients. The combination of either 10-SDOIT results and self-reported OD, or 8-SDOIT results and self-reported OD, were the best predictors of COVID-19, both with an AUC value of 0.87 (0.85 and 0.86 for the age-matched subjects). OD is a common symptom of COVID-19. A combination of self-reported smell deterioration and OD psychophysically evaluated using SDOIT appears to be a good predictor of COVID-19.

Indexed as

COVID-19Olfaction DisordersHumansOdorantsPandemicsSARS-CoV-2SmellanosmiaCOVID-19objectiveolfactorySDOIT

Identifiers

PMID34639486
PMCPMC8507979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.